← 返回

NK 细胞在溶瘤病毒治疗中的作用:是友还是敌?

英文原题:The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

查看英文原题

The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

PubMed 2024/06/28(内容时间) Vaccines (Basel) Q2 · IF 3.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

溶瘤病毒疗法(OVT)已成为一种有前景的癌症免疫疗法,并且由于其能够增加肿瘤免疫原性并增强宿主抗肿瘤免疫力,因此能够增强其他免疫疗法的效果。自然杀伤(NK)细胞是介导抗肿瘤反应的关键细胞成分,但其在介导OVT治疗效果中的作用却存在争议。本综述将讨论NK细胞如何影响OVT的利弊,以及如何利用这些知识开发有效策略,通过调节NK细胞来改善基于OVT的治疗效果。

展开英文摘要原文

Oncolytic virotherapy (OVT) has emerged as a promising cancer immunotherapy, and is capable of potentiating other immunotherapies due to its capacity to increase tumor immunogenicity and to boost host antitumor immunity.

Natural killer (NK) cells are a critical cellular component for mediating the antitumor response, but hold a mixed reputation for their role in mediating the therapeutic efficacy of OVT. This review will discuss the pros and cons of how NK cells impact OVT, and how to harness this knowledge for the development of effective strategies that could modulate NK cells to improve OVT-based therapeutic outcomes.

论文信息

作者
Franks ML、An JH、Leavenworth JW
单位
Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.United States
文献类型
综述
期刊
Vaccines2024 Jun 28
原文标识
PubMed 39066359 · DOI 10.3390/vaccines12070721